Clinicopathologic Profile And Treatment Outcomes Of Non-Sensitizing Egfr And Her2 (Erbb2) Activating Mutations In Nsclc: Results From A Single-Center Retrospective Study.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 22|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要